research glp 1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Discovery of GLP-1–Based Drugs for

( C ) Seahorse XFe24 traces of glucose oxidation, measured as the OCR by sequential injection of 20 mM glucose, 1 M oligomycin, 1 M FCCP [carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone], 1 M rotenone, and 2 M antimycin A into caSMCs cultured in normal (5.5 mmol/L) glucose media

and scientific collaboration with Bayer AG

Clinicians who stay current on this evolving research will be better prepared to guide patients through both the excitement and the limitations of these developing therapies

The role of glucagon and incretin hormones in weight management As early as 1906, clinicians observed that blood glucose uptake is significantly higher when glucose is absorbed through the gut than intravenous infusion